What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Compare volatility levels for Dividend Aristocrats ETF and apply practical tactics to manage risk and maximize stability.
22,003 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Alphatec (ATEC) is navigating a shifting spine device market. This guide breaks down expected 2025 earnings, key driv...
A QuidelOrtho Corp director purchases 10,000 shares amid a CFO retirement, sparking investor interest. This article e...
Turning Point Brands stock took a sharp drop this week as investors weighed a disappointing quarter and cautious guid...
Citi lifts its TMUS price target to $225, citing robust cash flow and a big buyback. The call comes as investors weig...
Waterfront properties can deliver strong returns, but they carry unique risks. This guide explains how to build solid...
Beaten-down stocks often hide big upside. Explore a practical, evidence-based approach to identifying a candidate tha...
In a crowded AI market, a stock nobody watching that quietly compounds growth could deliver outsized returns. This gu...
Seven months into fiscal 2026, the deficit surged to $955 billion, intensifying pressure on policymakers to restrain ...
Cisco and CrowdStrike rally prompt debate on which name makes the better short bet. The case centers on Cisco's margi...
Fed leadership shifts toward a hawkish path as Waller signals higher policy risk. Markets price in tighter loans and ...
Russia faces widening budget deficits as war spending outpaces revenue, pushing the economy toward a prolonged stretc...